Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josh Levitsky

Showing results (161-170 of 199) with videos related to

Pageof 20
Sort By:
Transplantation|February 26, 2015
Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter StudyElizabeth C Verna, Varun Saxena, James R Burton, et al.
The Journal of Clinical Endocrinology and Metabolism|November 23, 2016
Glycemic Control Reduces Infections in Post-Liver Transplant Patients: Results of a Prospective, Randomized StudyAmisha Wallia, Kathleen Schmidt, Diana Johnson Oakes, et al.
Clinical Transplants|August 7, 2014
HLA identical non-chimeric and HLA disparate chimeric renal transplant toleranceJoseph R Leventhal, James M Mathew, Suzanne Ildstad, et al.
The Lancet. Digital Health|April 16, 2021
Long-term mortality risk stratification of liver transplant recipients: real-time application of deep learning algorithms on longitudinal dataOsvald Nitski, Amirhossein Azhie, Fakhar Ali Qazi-Arisar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 2, 2020
Discovery and validation of a novel blood-based molecular biomarker of rejection following liver transplantationJosh Levitsky, Sumeet K Asrani, Thomas Schiano, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 16, 2019
Blood pressure control according to clinical practice guidelines is associated with decreased mortality and cardiovascular events among liver transplant recipientsLisa B VanWagner, Jane L Holl, Samantha Montag, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 4, 2018
Outcomes of immunosuppression minimization and withdrawal early after liver transplantationAbraham Shaked, Michele R DesMarais, Heather Kopetskie, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 18, 2014
The impact of coronary artery disease on outcomes after liver transplantationAnton I Skaro, Lorenzo G Gallon, Vadim Lyuksemburg, et al.
Hepatology (Baltimore, Md.)|November 14, 2019
Immunosuppression Withdrawal in Liver Transplant Recipients on SirolimusJosh Levitsky, Bryna E Burrell, Sai Kanaparthi, et al.
AJR. American Journal of Roentgenology|February 24, 2011
Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imagingYi Wang, Daniel R Ganger, Josh Levitsky, et al.
Pageof 20

Showing results (161-170 of 199) with videos related to

Sort By:
Pageof 20
Transplantation|February 26, 2015
Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter StudyElizabeth C Verna, Varun Saxena, James R Burton, et al.
The Journal of Clinical Endocrinology and Metabolism|November 23, 2016
Glycemic Control Reduces Infections in Post-Liver Transplant Patients: Results of a Prospective, Randomized StudyAmisha Wallia, Kathleen Schmidt, Diana Johnson Oakes, et al.
Clinical Transplants|August 7, 2014
HLA identical non-chimeric and HLA disparate chimeric renal transplant toleranceJoseph R Leventhal, James M Mathew, Suzanne Ildstad, et al.
The Lancet. Digital Health|April 16, 2021
Long-term mortality risk stratification of liver transplant recipients: real-time application of deep learning algorithms on longitudinal dataOsvald Nitski, Amirhossein Azhie, Fakhar Ali Qazi-Arisar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 2, 2020
Discovery and validation of a novel blood-based molecular biomarker of rejection following liver transplantationJosh Levitsky, Sumeet K Asrani, Thomas Schiano, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 16, 2019
Blood pressure control according to clinical practice guidelines is associated with decreased mortality and cardiovascular events among liver transplant recipientsLisa B VanWagner, Jane L Holl, Samantha Montag, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 4, 2018
Outcomes of immunosuppression minimization and withdrawal early after liver transplantationAbraham Shaked, Michele R DesMarais, Heather Kopetskie, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 18, 2014
The impact of coronary artery disease on outcomes after liver transplantationAnton I Skaro, Lorenzo G Gallon, Vadim Lyuksemburg, et al.
Hepatology (Baltimore, Md.)|November 14, 2019
Immunosuppression Withdrawal in Liver Transplant Recipients on SirolimusJosh Levitsky, Bryna E Burrell, Sai Kanaparthi, et al.
AJR. American Journal of Roentgenology|February 24, 2011
Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imagingYi Wang, Daniel R Ganger, Josh Levitsky, et al.
Pageof 20